In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma. (Record no. 19306434)

MARC details
000 -LEADER
fixed length control field 02208 a2200649 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515194432.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201002s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1532-1827
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1038/sj.bjc.6605448
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name El-Sahwi, K
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20100209
245 00 - TITLE STATEMENT
Title In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. British journal of cancer
Date of publication, distribution, etc. Jan 2010
300 ## - PHYSICAL DESCRIPTION
Extent 134-43 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adenocarcinoma, Papillary
General subdivision pathology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibody-Dependent Cell Cytotoxicity
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Line, Tumor
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Complement System Proteins
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cytotoxicity, Immunologic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dimerization
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Screening Assays, Antitumor
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Synergism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunoglobulin G
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element In Vitro Techniques
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interleukin-2
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Killer Cells, Natural
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphocytes
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptor, ErbB-2
General subdivision biosynthesis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Signal Transduction
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Trastuzumab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Uterine Neoplasms
General subdivision pathology
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bellone, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cocco, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cargnelutti, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Casagrande, F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bellone, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Abu-Khalaf, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Buza, N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tavassoli, F A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hui, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Silasi, D-A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Azodi, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schwartz, P E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rutherford, T J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pecorelli, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Santin, A D
773 0# - HOST ITEM ENTRY
Title British journal of cancer
Related parts vol. 102
-- no. 1
-- p. 134-43
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1038/sj.bjc.6605448">https://doi.org/10.1038/sj.bjc.6605448</a>
Public note Available from publisher's website

No items available.